Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan - Iran

World Journal of Gastroenterology

Volumn 11, Issue 26, 2005, Pages 4085-4089

  Alizadeh, Amir Houshang Mohammad ^a   Alavian, Seyed Moayed ^b   Jafari, Khalil ^c   Yazdi, Nastaran ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug abusers; Hepatitis C virus; Iran; Prisoners

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRISONER; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; VIRUS TRANSMISSION;

EID: 24144438931     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i26.4085     Document Type: Article

References (48)

1. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, Kaslow R, Ness P, Alter HJ. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905
3. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, Lau D, Hoofnagle JH. Hepatitis C in asymptomatic blood donors. Hepatology 1997; 26(Suppl 1): 29-33
4. Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur J Epidemiol 1994; 10: 687-694
5. Goldberg D, Cameron S, McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health 1998; 1: 95-97
6. Samuel MC, Doherty PM, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect 2001; 127: 475-484
7. Alter MJ. Hepatitis C virus infection in the United States. J Hepatol 1999; 31: 88-91
8. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-1097
9. Zali MR, Noroozi A, Amirrasooli H, Darvishi M. Prevalence of Anti-HCV antibody and routes of hematological transmission in addicts of Ghasr prison [in persian]. Pajouhesh 1998; 22: 26-32
10. Skipper C, Guy JM, Parkes J, Roderick P, Rosenberg WM. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut 2003; 52: 1500-1504
11. Crofts N, Stewart T, Hearne P, Ping XY, Breshkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995; 310: 285-288
12. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. Hepatitis C in state correctional facilities. Prev Med 1999; 28: 92-100
13. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000; 321: 78-82
14. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3: 121-126
15. Burattini M, Massad E, Rozman M, Azevedo R, Carvalho H. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Rev Saude Publica 2000; 34: 431-436
16. Reindollar RW. Hepatitis C and the correctional population. Am J Med 1999; 107: 100-103
17. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26 (3 Suppl 1): 62-65
18. Capoccia A, Ranieri R, Busnelli M, Passaretti B, Milella AM, Vecchi L. Serologic study on the prevalence of HIV, HBV infection and on the false positive reaction of VDRL at a prison. Minerva Med 1991; 82: 125-130
19. Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med 1993; 118: 139-145
20. Hoxie NJ, Chen MH, Prieve A, Haase B, Pfister J, Vergeront JM. HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ 1998; 97: 28-31
21. Merino-Conde E, Orozco JA, Rojo-Medina J, Tovar A. Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de Mexico. In Vivo 1994; 8: 621-623
22. Ito S, Yao DF, Nii C, Hibino S, Kamamura M, Nisikado T, Honda H, Shimizu I, Meng XY. Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1993; 8: 232-237
23. Soni PN, Tait DR, Kenoyer DG, Fernandes-Costa F, Naicker S, Gopaul W, Simjee AE. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993; 40: 65-68
24. Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med 2003; 138: 187-190
25. Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997; 166: 127-130
26. Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000; 33: 27-30
27. Claudon-Charpentier A, Hoibian M, Glasser P, Lalanne H, Pasquali JL. Drug-addicted prisoners: seroprevalence of human immunodeficiency virus and hepatitis B and C virus soon after the marketing of buprenorphine. Rev Med Interne 2000; 21: 505-509
28. Kar P, Gangwal P, Budhiraja B, Singhal R, Jain A, Madan K, Gupta RK, Barua SP, Nath MC. Analysis of serological evidence of different hepatitis viruses in acute viral hepatitis in prisoners in relation to risk factors. Indian J Med Res 2000; 112: 128-132
29. Ford PM, White C, Kaufmann H, MacTavish J, Pearson M, Ford S, Sankar-Mistry P, Connop P. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995; 153: 1605-1609
30. Pinducciu G, Arnone M, Piu G, Usai M, Melis A, Pintus L, Pitzus F. Prevalence of hepatitis virus (HBV and HCV) and HIV-1 infections in a prison community. Ann Ig 1990; 2: 359-363
31. Nara K, Kawano M, Igarashi M. Prevalence of hepatitis C virus and human immunodeficiency virus infection among female prison inmates in Japan [In Japanese]. Nippon Koshu Eisei Zasshi 1997; 44: 55-60
32. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993; 12: 673-676
33. [No authors listed]. Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain [In Spanish]. Rev Esp Salud Publica 1998; 72: 43-51
34. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9: 566-569
35. van den Hoek JA, van Haastrecht HJ, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823-826
36. Chamot E, de Saussure P, Hirschel B, Deglon JJ, Perrin LH. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 1992; 6: 430-431
37. Bird AG, Gore SM, Burns SM, Duggie JG. Study of infection with HIV and related risk factors in young offenders' institution. BMJ 1993; 307: 228-231
38. Gore SM, Bird AG, Burns SM, Goldberg DJ, Ross AJ, Macgregor J. Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ 1995; 310: 293-296
39. Bellis MA, Weild AR, Beeching NJ, Mutton KJ, Syed Q. Prevalence of HIV and injecting drug use in men entering Liverpool prison. BMJ 1997; 315: 30-31
40. Gaughwin MD, Douglas RM, Liew C, Davies L, Mylvaganam A, Treffke H, Edwards J, Ali R. HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS 1991; 5: 845-851
41. Stratton E, Sweet L, Latorraca-Walsh A, Gully PR. Hepatitis C in Prince Edward Island: a descriptive review of reported cases, 1990-1995. Can J Public Health 1997; 88: 91-94
42. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, Cortes A, Vega JL, Gonzalez F, Arenas JI. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995; 7: 237-241
43. Crawford RJ, Gillon J, Yap PL, Brookes E, McOmish F, Simmonds P, Dow BC, Follett EA. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med 1994; 4: 121-124
44. Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. N Z Med J 1995; 108: 364-366
45. Tsega E, Nordenfelt E, Hansson BG. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg 1995; 89: 171-174
46. Cohen D, Scribner R, Clark J, Cory D. The potential role of custody facilities in controlling sexually transmitted diseases. Am J Public Health 1992; 82: 552-556
47. Heimberger TS, Chang HG, Birkhead GS, DiFerdinando GD, Greenberg AJ, Gunn R, Morse DL. High prevalence of syphilis detected through a jail screening program. A potential public health measure to address the syphilis epidemic. Arch Intern Med 1993; 153: 1799-1804
48. Polonsky S, Kerr S, Harris B, Gaiter J, Fichtner RR, Kennedy MG. HIV prevention in prisons and jails: obstacles and opportunities. Public Health Rep 1994; 109: 615-625